Action of db-cAMP on the bystander effect and chemosensitivity through connexin 43 and Bcl-2-mediated pathways in medulloblastoma cells

Oncology Reports

Volumn 28, Issue 3, 2012, Pages 969-976

  Sun, Peixin ^a,b   Liu, Yunhui ^a   Ying, Haoqiang ^a   Li, Shaoyi ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b LIAONING CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Bcl 2; Bystander effect; Chemosensitivity; Connexin 43; Db cAMP; Medulloblastoma

Indexed keywords

BUCLADESINE; CONNEXIN 43; CYCLIC AMP; GANCICLOVIR; PROTEIN BCL 2; PROTEIN INHIBITOR; SITIMAGENE CERADENOVEC; TEMOZOLOMIDE; TENIPOSIDE; THYMIDINE KINASE;

APOPTOSIS; ARTICLE; BYSTANDER EFFECT; CANCER CELL; CELL COMMUNICATION; CELL FUNCTION; CHEMOSENSITIVITY; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; GAP JUNCTION; GAP JUNCTIONAL INTRACELLULAR COMMUNICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SIGNALING; MEDULLOBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BUCLADESINE; BYSTANDER EFFECT; CELL LINE, TUMOR; CELL SURVIVAL; CEREBELLAR NEOPLASMS; CONNEXIN 43; DACARBAZINE; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; GAP JUNCTIONS; GOSSYPOL; HUMANS; MEDULLOBLASTOMA; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; SIGNAL TRANSDUCTION; SIMPLEXVIRUS; TENIPOSIDE; THYMIDINE KINASE;

EID: 84865311423     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1900     Document Type: Article

References (34)

1. Taylor RE, Bailey CC, Robinson K, et al: Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for non-metastatic medulloblastoma: the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study. J Clin Oncol 21: 1581-1591, 2003.
2. Zeltzer PM, Boyett JM, Finlay JL, et al: Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 Randomized Phase III Study. J Clin Oncol 17: 832-845, 1999.
3. Kozarsky KF and Wilson JM: Gene therapy: adenovirus vectors. Curr Opin Genet Dev 3: 499-503, 1993.
4. Pützer BM, Bramson JL, Addison CL, et al: Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer. Hum Gene Ther 9: 707-718, 1998.
5. Nishi M, Kumar NM and Gilula NB: Developmental regulation of gap junction gene expression during mouse embryonic develop ment. Dev Biol 146: 117-130, 1991.
6. Houghton FD: Role of gap junctions during early embryo develop ment. Reproduction 129: 129-135, 2005.
7. Vinken M, Vanhaecke T, Papeleu P, et al: Connexins and their channels in cell growth and cell death. Cell Signal 18: 592-600, 2006.
8. Trosko JE and Chang CC: Modulation of cell-cell communication in the cause and chemoprevention/chemotherapy of cancer. Biofactors 12: 259-263, 2000.
9. Mesnil M, Piccoli C, Tiraby G, et al: Bystander killing of cancer cells by herpes virus thymidine kinase gene is mediated by connexins. Proc Natl Acad Sci USA 93: 1831-1835, 1996.
10. Elshami AA, Saavedra A, Zhang H, et al: Gap junctions play a role in the 'bystander effect' of the herpes simplex thymidine kinase/ganciclovir system in vitro. Gene Ther 3: 85-92, 1996.
11. Alexander DB and Goldberg GS: Transfer of biologically important molecules between cells through gap junction channels. Curr Med Chem 10: 2045-2058, 2003.
12. Yamasaki H: Gap junction intercellular communication carcinogenesis. Carcinogenesis 11: 1051-1058, 1990.
13. Yamasaki H, Mesnil M, Omori Y, et al: Intercellular communication and carcinogenesis. Mutat Res 333: 181-188, 1995.
14. Zhou DR, Zhou YC, Cui GH, et al: Gossypol repressed the gap junctional intercellular communication between Sertoli cells by decreasing the expression of Connexin43. Toxicol In Vitro 22: 1719-1725, 2008.
15. Rosolen A, Frascella E, di Francesco C, Todesco A, et al: In vitro and in vivo antitumor effect of retrovirus mediated herpes simplex thymidine kinase gene transfer in human medulloblastoma. Gene Ther 5: 113-120, 1998.
16. Huang RP, Hossain MZ, Huang R, et al: Connexin 43 (cx43) enhances chemotherapy-induced apoptosis in human glioblastoma cells. Int J Cancer 92: 130-138, 2001.
17. Pu K, Li SY, Gao Y, et al: Bystander effect in suicide gene therapy using immortalized neural stem cells transduced with herpes simplex virus thymidine kinase gene on medulloblastoma regression. Brain Res 1369: 245-252, 2011.
18. Miyashita T and Reed JC: Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81: 151-157, 1993.
19. Piche A, Grim J, Rancourt C, et al: Modulation of Bcl-2 protein levels by an intracellular anti-Bcl-2 single-chain antibody increases drug-induced cytotoxicity in the breast cancer cell line MCF-7. Cancer Res 58: 2134-2140, 1998.
20. Reed JC, Miyashita T, Takayama S, et al: BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J Cell Biochem 60: 23-32, 1996.
21. Jimenez T, Fox WP, Naus CC, et al: Connexin over-expression differentially suppresses glioma growth and contributes to the bystander effect following HSV-thymidine kinase gene therapy. Cell Commun Adhes 13: 79-92, 2006.
22. Zhang A, Wang Qy, Han Z, et al: Relationship between the expression of connexin43 and bystander effect of suicide gene therapy in ovarian cancer. J Huazhong Univ Sci Technolog Med Sci 24: 476-479, 2004.
23. Carystinos GD, Alaoui-Jamali MA, Phipps J, et al: Upregulation of gap junctional intercellular communication and connexin 43 expression by cyclic-AMP and all-trans-retinoic acid is associated with glutathione depletion and chemosensitivity in neuroblastoma cells. Cancer Chemother Pharmacol 47: 126-132, 2001.
24. Chen TC, Hinton DR, Zidovetzki R and Hofman FM: Upregulation of the cAMP/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas. Lab Invest 78: 165-174, 1998.
25. Goodenough DA, Goliger JA and Paul DL: Connexins, connexons, and intercellular communication. Annu Rev Biochem 65: 475-502, 1996.
26. Laird DW, Puranam KL and Revel JP: Turnover and phosphorylation dynamics of connexin43 gap junction protein in cultured cardiac myocytes. Biochem J 273: 67-72, 1991.
27. Granot I and Dekel N: Phosphorylation and expression of connexin-43 ovarian gap junction protein are regulated by luteinizing hormone. J Biol Chem 269: 30502-30509, 1994.
28. Burt JM and Spray DC: Ionotropic agents modulate gap junctional conductance between cardiac myocytes. Am J Physiol 254: H1206-H1210, 1988.
29. Godwin AJ, Green LM, Walsh MP, et al: In situ regulation of cell-cell communication by the cAMP-dependent protein kinase and protein kinase C. Mol Cell Biochem 127-128: 293-307, 1993.
30. Vile RG, Nelson JA, Castleden S, et al: Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. Cancer Res 54: 6228-6234, 1994.
31. Caruso M, Panis Y, Gagandeep S, et al: Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci USA 90: 7024-7028, 1993.
32. Samejima Y and Meruelo D: 'Bystander killing' induces apoptosis and is inhibited by forskolin. Gene Ther 2: 50-58, 1995.
33. Freeman SM, Abboud CN, Whartenby KA, et al: The 'bystander effect': tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 53: 5274-5283, 1993.
34. Ram Z, Walbridge S, Shawker T, et al: The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature growth of 9L gliomas in rats. J Neurosurg 81: 256-260, 1994.